title: Hyperthermic Intra-Thoracic Chemotherapy (HITeC) for the management of recurrent ovarian cancer involving the pleural cavity.
abstract: •Intra-thoracic chemotherapy is an option for heavily pre-treated patients with recurrent ovarian cancer.•HITeC is technically feasible and well tolerated.
authors.affiliation: Seidman Cancer Center, Cleveland, OH, United States.
authors.forename: S
authors.initials: S
authors.lastname: Singh
authors.affiliation: Seidman Cancer Center, 11100 Euclid Ave, Cleveland, OH 44106, United States.
authors.forename: A
authors.initials: A
authors.lastname: Armstrong
authors.affiliation: Seidman Cancer Center, Cleveland, OH, United States.
authors.forename: J
authors.initials: J
authors.lastname: Robke
authors.affiliation: Seidman Cancer Center, Cleveland, OH, United States.
authors.forename: S
authors.initials: S
authors.lastname: Waggoner
authors.affiliation: Cleveland Clinic Foundation, Cleveland, OH, United States.
authors.forename: R
authors.initials: R
authors.lastname: Debernardo
keywords: Intra-thoracic chemotherapy; Ovarian cancer